BiophytisBPTSY 18 Pretax Margin % is % as of Jun. 2025. GuruFocus rates BPTSY with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 947 Biotechnology companies, Biophytis ranks worse than 105596.52% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Biophytis's Pre-Tax Income for the
six
months ended in Jun. 2025 was $-4.00 Mil. Biophytis's Revenue for the
six
months ended in Jun. 2025 was $0.00 Mil. Therefore, Biophytis's pretax margin for the quarter that ended in Jun. 2025 was %.
The historical rank and industry rank for Biophytis's Pretax Margin % or its related term are showing as below:
BPTSY's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -92.22 * Ranked among companies with meaningful Pretax Margin % only.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Biophytis Pretax Margin % Related Terms
Biophytis Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Biophytis's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BPTSY vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, Biophytis's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biophytis Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Biophytis's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Biophytis's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biophytis (BPTSY) has a Pretax Margin % of % as of Jun. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Biophytis and its competitors. According to the industry distribution chart, Biophytis ranks #999999 out of 947 companies in the Biotechnology industry.
Is Biophytis' Pretax Margin % too high?
Biophytis' current Pretax Margin % is %. Based on the distribution chart, Biophytis ranks #999999 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Biophytis has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Biophytis' Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Biophytis ranks #999999 out of 947 companies for Pretax Margin %. This places Biophytis in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Biophytis and its competitors. Biophytis's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biophytis stock overvalued right now?
Biophytis (BPTSY) has a current Pretax Margin % of %. The current Pretax Margin % is %. Biophytis' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Biophytis (BPTSY), the current Pretax Margin % is % as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biophytis SA is a France-based clinical-stage biotechnology company engaged in the development of drug candidates for the treatment of age-related and respiratory diseases. The company focuses on therapies that target degenerative processes associated with aging and improve functional outcomes. Its drug candidate, BIO101, is an orally administered small molecule under development for neuromuscular and respiratory indications, including sarcopenia, Duchenne muscular dystrophy (DMD), and respiratory failure.
18GF Score
Get the complete analysis for BPTSY
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BPTSY has been successfully added to your 
